Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
IMMPLACATE logo — company profile

IMMPLACATE

Founded 2017 2 employees

General Information

Company Name IMMPLACATE
Founded Year 2017
Employees 2
Social

Get notified when IMMPLACATE moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About IMMPLACATE

IMMPLACATE is a preclinical stage cell therapy company focusing on developing educated mesenchymal cells (EMCs) for the treatment of unwanted immune responses. The company's pioneering approach aims to address the unmet needs of patients with acute and chronic immune disorders, who face heightened mortality risks and diminished quality of life. Furthermore, the limitations and potential risks associated with current pharmaceutical options underscore the urgency for innovative and safer alternatives. Founded in 2017, IMMPLACATE's mission revolves around leveraging science-based EMC therapy to enhance the wellbeing of individuals battling immune-related conditions. However, detailed information regarding specific industries, headquarters, past investments, and notable investors is currently unavailable.

No funding data available for IMMPLACATE yet.

Get notified when IMMPLACATE raises funding

IMMPLACATE Alternatives & Competitors

IMMPLACATE vs
Aiolos Bio
Aiolos Bio United States

At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease a...

Series A
3 employees
Biopharma, Biotechnology
IMMPLACATE vs
Immunservice
Immunservice

Immunservice is a biopharmaceutical company addressing orphan disease indications as well as large m...

Series C
3 employees
Biotechnology, Developer Tools
IMMPLACATE vs
Omnis Health Life and Wellness Center
Omnis Health Life and Wellness Center United States

EMPOWERING THROUGH RECOVERY Omnis Health Life Wellness Center is a provider of treatment options fo...

9 employees
Health Care, Health and Wellness

FAQ About IMMPLACATE

IMMPLACATE is a preclinical stage cell therapy company. To our knowledge, we are the first company to clinically develop educated mesenchymal cells (EMCs) for treatment of unwanted immune responses. Patients with acute and chronic immune disorders can have an increased risk of death and a reduced q...
IMMPLACATE was founded in 2017.
IMMPLACATE has approximately 2 employees.
Top alternatives and competitors to IMMPLACATE include Aiolos Bio, Immunservice, Omnis Health Life and Wellness Center, Neuronity, A New Start, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IMMPLACATE and Aiolos Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors IMMPLACATE and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy